Hereditary Leiomyomatosis and Renal Cell Cancer

Medical and Research Council

Julie Adam, Ph.D.

Researcher, Nuffield Department of Medicine, Oxford, UK

 Professor, Head of the Department of Clinical Genetics, HUSLAB ,Helsinki University Hospital, Finland

Chair of Urology, Upstate Medical Center, Syracuse, NY, USA

 Dermatologist and Associate Editor of the Journal of the American Academy of Dermatology, Greenwood Village, CO, USA

Programme Leader in Cancer Metabolism, MRC Cancer Unit University of Cambridge, UK

 Research Group Leader, Beatson Institute of Cancer Research, Glasgow, Scotland, UK

Chief, Urologic Oncology Branch, National Cancer Institute*, USA

Professor of Medical Genetics and Genomic Medicine, University of Cambridge, UK

Director of Engagement and Outreach, VHL Alliance, USA

 Consultant Clinical Geneticist, VU University, Amsterdam, The Netherlands

Associate Professor, Department of Medicine, Harvard Medical School, USA

 Professor of Oncogenetics and Chair, National Expert Centre for Rare Cancers PREDIR, Le Kremlin-Bicêtre, France

Laura S. Schmidt, Ph.D.

Urologic Oncology Branch, National Cancer Institute*, USA

Pamela Stratton, M.D.

Gynecologist, National Institute of Child Health and Human Development, US-NIH,Bethesda, MD, USA

Assistant Professor UTHSCSA, Urology, San Antonio, TX, USA

CEO and Medical Director of Lucence Diagnostics Pte Ltd.

Investigator, Dermatology Branch, National Cancer Institute*, USA

This is a staging enviroment